Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 9thDecember 2014
Summary The industry analysis specialist, has released its new report, “Narcolepsy Therapeutics Pipeline Assessment and Market Forecasts to 2019�. The report is an essential source of information and analysis on the global Narcolepsy Therapeutics market. The report identifies the key trends shaping and driving the global Narcolepsy Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Narcolepsy Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-narcolepsy-therapeutics-pipeline-assessment-and-market-forecasts135222 Scope The report provides information on the key drivers and challenges of the Narcolepsy Therapeutics market. Its scope includes Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Narcolepsy Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Narcolepsy Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Narcolepsy Therapeutics market. - Analysis of key recent licensing and partnership agreements in Narcolepsy Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Narcolepsy Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Narcolepsy Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Narcolepsy Therapeutics market landscape? – Identify, understand and capitalize. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Narcolepsy Therapeutics - Introduction 2.1 Disease Overview 2.1.1 Narcolepsy with Cataplexy 2.1.2 Narcolepsy without Cataplexy 2.2 Epidemiology 2.2.1 Prevalence 2.2.2 Quality of Life Parameters 2.3 Etiology and Pathophysiology 2.4 Signs and Symptoms 2.5 Diagnosis 2.5.1 Actigraphy 2.5.2 Multiple Sleep Latency Test (MSLT) 2.5.3 Polysomnography (PSG) 2.5.4 Hypocretin Test 2.6 Treatment and Management Options 2.6.1 Non-Pharmacological Treatment 2.6.2 Pharmacological Treatment 2.7 Referral Pathway Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.8 GlobalData Pipeline Report Guidance 3 NarcolepsyTherapeutics - Market Characterization 3.1 Overview 3.2 Narcolepsy Therapeutics Market Size (2006-2011) - Global 3.3 Narcolepsy Therapeutics Market Forecast (2011-2019) - Global 3.4 Narcolepsy Therapeutics Market Size (2006-2011) - The US 3.5 Narcolepsy Therapeutics Market Forecast (2011-2019) - The US 3.6 Narcolepsy Therapeutics Market Size (2006-2011) - France 3.7 Narcolepsy Therapeutics Market Forecast (2011-2019) - France 3.8 Narcolepsy Therapeutics Market Size (2006-2011) - Germany 3.9 Narcolepsy Therapeutics Market Forecast (2011-2019) - Germany 3.10 Narcolepsy Therapeutics Market Size (2006-2011) - Italy 3.11 Narcolepsy Therapeutics Market Forecast (2011-2019) - Italy 3.12 Narcolepsy Therapeutics Market Size (2006-2011) - Spain 3.13 Narcolepsy Therapeutics Market Forecast (2011-2019) - Spain 3.14 Narcolepsy Therapeutics Market Size (2006-2011) - The UK 3.15 Narcolepsy Therapeutics Market Forecast (2011-2019) - The UK 3.16 Narcolepsy Therapeutics Market Size (2006-2011) - Japan 3.17 Narcolepsy Therapeutics Market Forecast (2011-2019) - Japan 3.18 Drivers and Barriers for the Narcolepsy Therapeutics Market 3.18.1 Drivers for the Narcolepsy Therapeutics Market 3.18.2 Barriers for the Narcolepsy Therapeutics Market 3.19 Opportunity and Unmet Need Analysis 3.20 Key Takeaway 4 Narcolepsy Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles for the Major Marketed Products in the Narcolepsy Therapeutics Market 4.3.1 Provigil (modafinil) 4.3.2 Nuvigil (armodafinil) 4.3.3 Xyrem (sodium oxybate) 4.4 Key Takeaway 5 Narcolepsy Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Narcolepsy Therapeutics Pipeline - Pipeline by Phases of Development 5.3.1 Narcolepsy Therapeutics - Phase III Pipeline 5.3.2 Narcolepsy Therapeutics - Phase II Pipeline 5.3.3 Narcolepsy Therapeutics - Pre-Clinical Pipeline Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
5.3.4 Narcolepsy Therapeutics -Discovery Pipeline 5.3.5 Technology Trends Analytic Framework 5.4 Narcolepsy Therapeutics Market - Pipeline by Mechanism of Action 5.5 Molecule Profile for Promising Drugs under Clinical Development 5.5.1 BF2.649 (pitolisant) 5.6 Key Takeaway 6 Narcolepsy Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 6.2 Clinical Trials by Phase 6.3 Clinical Trials by Trial Status 6.4 Prominent Sponsors 6.5 Top Companies Participating in Narcolepsy Therapeutics Clinical Trials 7 Narcolepsy Therapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Narcolepsy Therapeutics: Implications for Future Market Competition 8 Narcolepsy Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 Bioprojet 8.2.2 Jazz Pharmaceuticals, Inc. 8.2.3 Teva Pharmaceuticals 9 Narcolepsy Therapeutics - Licensing and Partnership Deals 10 Narcolepsy Therapeutics - Appendix 10.1 Market Definitions 10.2 Abbreviations 10.3 Methodology 10.3.1 Coverage 10.3.2 Secondary Research 10.3.3 Forecasting 10.3.4 Primary Research 10.3.5 Expert Panel Validation 10.4 Contact Us 10.5 Disclaimer 10.6 Bibliography
List Of Tables
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 1: Narcolepsy Therapeutics Market, Global, Revenue ($m), 2006-2011 Table 2: Narcolepsy Therapeutics Market, Global, Forecast ($m), 2011-2019 Table 3: Narcolepsy Therapeutics Market, Global, Revenue ($m), 2006-2011 Table 4: Narcolepsy Therapeutics Market, The US, Forecasts ($m), 2011-2019 Table 5: Narcolepsy Therapeutics Market, France, Revenue ($m), 2006-2011 Table 6: Narcolepsy Therapeutics Market, France, Forecasts ($m), 2011-2019 Table 7: Narcolepsy Therapeutics Market, Germany, Revenue ($m), 2006-2011 Table 8: Narcolepsy Therapeutics Market, Germany, Forecasts ($m), 2011-2019 Table 9: Narcolepsy Therapeutics Market, Italy, Revenue ($m), 2006-2011 Table 10: Narcolepsy Therapeutics Market, Italy, Forecasts ($m), 2011-2019 Table 11: Narcolepsy Therapeutics Market, Spain, Revenue ($m), 2006-2011 Table 12: Narcolepsy Therapeutics Market, Spain, Forecasts ($m), 2011-2019 Table 13: Narcolepsy Therapeutics Market, The UK, Revenue ($m), 2006-2011 Table 14: Narcolepsy Therapeutics Market, The UK, Forecasts ($m), 2011-2019 Table 15: Narcolepsy Therapeutics Market, Japan, Revenue ($m), 2006-2011 Table 16: Narcolepsy Therapeutics Market, Japan, Forecasts ($m), 2011-2019 Table 17: Average Sleep Latencies (In Minutes) on The MWT at Baseline for the Controlled Trials Table 18: Percentages of Patients Who Showed Degree of Improvement on the CGI-C in the Clinical Trials Table 19: Average Baseline Sleep Latency and Change from Baseline at Final Visit (MWT and MSLT in minutes) Table 20: Clinical Global Impression of Change (CGI-C) Table 21: Summary of Outcomes in Clinical Trials Supporting the Efficacy of Sodium Oxybate Table 22: Clinical Global Impression of Change in Day and Nighttime Symptoms Table 23: Narcolepsy Therapeutics - Phase III Pipeline, 2011 Table 24: Narcolepsy Therapeutics - Phase II Pipeline, 2011 Table 25: Narcolepsy Therapeutics - Pre-Clinical Pipeline, 2011 Table 26: Narcolepsy Therapeutics - Discovery Pipeline, 2011 Table 27: Narcolepsy Therapeutics - Clinical Trials by Country, 2011 Table 28: Narcolepsy Therapeutics - Clinical Trials by Phase, 2011 Table 29: Narcolepsy Therapeutics - Clinical Trials by Status Table 30: Narcolepsy Therapeutics - Prominent Sponsors, 2011 Table 31:Narcolepsy Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011 Table 32: Bioprojet - Pipeline for Narcolepsy, 2011 Table 33: Narcolepsy Therapeutics, Global, Deals, 2009-2011
List Of Figures Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 1: Pharmacological Treatment of Narcolepsy Figure 2: Referral Pathway for Narcolepsy Figure 3: Narcolepsy Therapeutics Market, Global, Revenue ($m), 2006-2011 Figure 4: Narcolepsy Therapeutics Market, Global, Forecast ($m), 2011-2019 Figure 5: Narcolepsy Therapeutics Market, the US, Revenue ($m), 2006-2011 Figure 6: Narcolepsy Therapeutics Market, The US, Forecast ($m), 2011-2019 Figure 7: Narcolepsy Therapeutics Market, France, Revenue ($m), 2006-2011 Figure 8: Narcolepsy Therapeutics Market, France, Forecast ($m), 2011-2019 Figure 9: Narcolepsy Therapeutics Market, Germany, Revenue ($m), 2006-2011 Figure 10: Narcolepsy Therapeutics Market, Germany, Forecast ($m), 2011-2019 Figure 11: Narcolepsy Therapeutics Market, Italy, Revenue ($m), 2006-2011 Figure 12: Narcolepsy Therapeutics Market, Italy, Forecast ($m), 2011-2019 Figure 13: Narcolepsy Therapeutics Market, Spain, Revenue ($m), 2006-2011 Figure 14: Narcolepsy Therapeutics Market, Spain, Forecast ($m), 2011-2019 Figure 15: Narcolepsy Therapeutics Market, The UK, Revenue ($m), 2006-2011 Figure 16: Narcolepsy Therapeutics Market, The UK, Forecast ($m), 2011-2019 Figure 17: Narcolepsy Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 18: Narcolepsy Therapeutics Market, Japan, Forecast ($m), 2011-2019 Figure 19: Opportunity and Unmet Need for EDS in the Narcolepsy Therapeutics Market Figure 20: Opportunity and Unmet Need for Cataplexy in the Narcolepsy Therapeutics Market Figure 21: Narcolepsy Therapeutics - Strategic Competitor Assessment, 2011 Figure 22: Narcolepsy Therapeutics - Pipeline by Phase of Development, 2011 Figure 23: Narcolepsy Therapeutics - Technology Trends Analytics Framework, 2011 Figure 24: Narcolepsy Therapeutics - Technology Trends Analytics Framework - Description, 2011 Figure 25: Narcolepsy Therapeutics - Pipeline by Mechanism of Action, 2011 Figure 26: Clinical Trial Details of BF2.649 (pitolisant) Figure 27: Narcolepsy Therapeutics - Clinical Trials by Country, 2011 Figure 28: Narcolepsy Therapeutics - Clinical Trials by Phase, 2011 Figure 29: Narcolepsy Therapeutics - Clinical Trials by Status, 2011 Figure 30: Narcolepsy Therapeutics - Overall Sponsors, 2011 Figure 31: Narcolepsy Therapeutics - Prominent Sponsors, 2011 Figure 32: Narcolepsy Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011 Figure 33: Narcolepsy Therapeutics Market, Drivers and Restraints 2011 Figure 34: Implications for Future Market Competition in the Narcolepsy Market, 2011 Figure 35: Narcolepsy Therapeutics Market - Pipeline by Company, 2011 Figure 36: GlobalData Market Forecasting Model Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Amnesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018 Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018 Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hepatic Encephalopathy - Pipeline Assessment and Market Forecasts to 2019 Diabetic Gastroparesis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Pancreatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
To know more on Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-narcolepsytherapeutics-pipeline-assessment-and-market-forecasts-135222
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/